Description: Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Home Page: www.willowbio.com
202, 1201-5th Street SW
Calgary,
AB
T2R 0Y6
Canada
Phone:
403 910 5140
Officers
| Name | Title |
|---|---|
| Mr. Travis Doupe | Chief Financial Officer |
| Dr. Chris Savile | President, Director & CEO |
| Mr. Sanjib Singh Gill L.L.B. | Corporate Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 54.8851 |
| Price-to-Sales TTM: | 4.2379 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 19 |